Clinical Trial Update: Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents

View source ↗

Summary

This clinical trial aims to evaluate the efficacy of Xeomin (incobotulinumtoxinA) for migraines in patients with traumatic brain injury, with a comparator group…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine
• Traumatic Brain Injury

Drugs mentioned

• XEOMIN (INCOBOTULINUMTOXINA)

Snippet

Sponsor: Uniformed Services University of the Health Sciences | Conditions: Migraine, Traumatic Brain Injury | Status: RECRUITING